Mynd.ai gets NYSE American late-filing notice
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Mynd.ai, Inc. reported that it received a notice from NYSE American on May 18, 2026 stating it is not in compliance with continued listing requirements because it failed to timely file its Annual Report on Form 20-F for the year ended December 31, 2025 with the SEC.
The Form 20-F was due on May 15, 2026. Mynd.ai has an initial six-month cure period from that due date to file the report and regain compliance, with a possible additional six-month cure period at the exchange’s discretion. Its American Depositary Shares continue to trade on NYSE American while it works with advisors and auditors to complete the filing, but there is no assurance it will ultimately meet all listing standards.
Positive
- None.
Negative
- NYSE American non-compliance notice for late Form 20-F: Mynd.ai failed to file its Annual Report on Form 20-F for the year ended December 31, 2025 by the May 15, 2026 deadline, triggering a continued listing deficiency and potential future suspension or delisting if compliance is not restored within the cure periods.
Insights
Late Form 20-F filing triggers NYSE American listing deficiency risk.
Mynd.ai has missed the May 15, 2026 deadline for its Form 20-F, prompting a NYSE American notice under Section 1007. The company now faces a defined cure timeline to restore compliance through completion of its audited annual report.
The notice grants an initial six-month cure period from the due date, with a potential additional six months at the exchange’s discretion. Suspension or delisting procedures become possible if the filing is not completed within these windows, though ADS trading continues while the company remains otherwise compliant.
Management attributes the delay to accounting judgments and required disclosures for the year ended December 31, 2025, and states it is working with advisors and auditors. The company expresses an intention to file within the initial cure period but explicitly notes there is no assurance of ultimately meeting all NYSE American listing standards.
Key Figures
Key Terms
continued listing requirements regulatory
Annual Report on Form 20-F regulatory
Section 1007 of the NYSE American Company Guide regulatory
Initial Cure Period regulatory
Additional Cure Period regulatory
forward-looking statements regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Mynd.ai (MYND) receive a NYSE American non-compliance notice?
How long does Mynd.ai have to cure its late Form 20-F filing?
What happens if Mynd.ai does not file its Form 20-F within the cure period?
Why was Mynd.ai unable to file its Form 20-F on time?
Does Mynd.ai guarantee it will regain NYSE American compliance?
AI-generated analysis. How Rhea-AI works. Not financial advice.